Values Added Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
976
+126
+15% +$129K 0.42% 46
2026
Q1
$782K Sell
850
-122
-13% -$124K 0.33% 55
2025
Q4
$1.04M Buy
972
+56
+6% +$53.5K 0.44% 47
2025
Q3
$699K Buy
916
+2
+0.2% +$1.49K 0.31% 59
2025
Q2
$712K Buy
914
+28
+3% +$21.8K 0.35% 56
2025
Q1
$732K Sell
886
-86
-9% -$71.6K 0.41% 46
2024
Q4
$750K Buy
972
+606
+166% +$502K 0.43% 44
2024
Q3
$324K Buy
366
+17
+5% +$15.3K 0.2% 78
2024
Q2
$316K Buy
349
+57
+20% +$45.6K 0.23% 68
2024
Q1
$227K Buy
+292
New +$208K 0.18% 81

Other funds holding LLY

Values Added Financial's LLY Position: Q2 2026 in Review

Values Added Financial increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $129K and bringing the position to 976 shares worth $1.17M. The position accounts for 0.42% of the portfolio, ranked #46.

Values Added Financial first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Values Added Financial held 976 shares of Eli Lilly worth $1.17M as of Q2 2026.
  • Values Added Financial bought 126 Eli Lilly shares in Q2 2026, an estimated $129K.
  • Eli Lilly made up 0.42% of Values Added Financial's portfolio in Q2 2026, its #46 holding.
  • Values Added Financial first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Values Added Financial's 13F filing for Q2 2026, filed 27 Jul 2026.